Profile
AHPI ABT BSX-PA SYK MDT BSX
Company Name Allied Healthcare Products, Inc. Abbott Laboratories Boston Scientific Corporation Stryker Corporation Medtronic plc Boston Scientific Corporation
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap - $196.11B $175.45B $139.91B $127.61B $110.83B
Employees 0.15K 114.00K 45.00K 53.00K 95.00K 53.00K
CEO Daniel C. Dunn Robert Ford Michael F. Mahoney Kevin A. Lobo Geoffrey Straub Martha Michael F. Mahoney
Ratings
AHPI ABT BSX-PA SYK MDT BSX
Quant Rating Score 3 2 3 3 1
Quant Rating Neutral Sell Neutral Neutral Strong Sell
Trading
AHPI ABT BSX-PA SYK MDT BSX
Last Close $0.004 $130.03 $122.18 $360.13 $96.28 $101.76
High 52 $0.55 $140.22 $122.18 $403.53 $98.43 $108.14
Low 52 - $111.1 $122.18 $337.28 $79.61 $88.03
Price vs. 52 Week High -99.27 % -7.27 % 0 % -10.76 % -2.18 % -5.9 %
Price vs. 52 Week Low 0 % 17.04 % 0 % 6.77 % 20.94 % 15.6 %
Total Return
AHPI ABT BSX-PA SYK MDT BSX
1 Month Return 0 % 1.16 % 0 % -3.82 % 0.52 % 2.54 %
3 Month Return 0 % -0.18 % 0 % -5.68 % 3.74 % -1.25 %
6 Month Return 0 % -3.54 % 0 % -8.65 % 11.38 % -4.04 %
9 Month Return 0 % -0.12 % 0 % -6.61 % 11.86 % -3.41 %
YTD Return 0 % 14.96 % 0 % 0.02 % 20.53 % 13.93 %
1 Year Return -99.27 % 11.01 % 0 % -7.35 % 13.27 % 12.65 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
AHPI ABT BSX-PA SYK MDT BSX
Dividend Yield Percentage (TTM) - 2.13 % - 0.93 % 2.84 % -
Dividend Paid and Capex Coverage Ration (TTM) - 1.46 % 5.44 % 2.47 % 1.29 % 5.44 %
Dividend Per Share (TTM) - 2.4 % - 3.4 % 2.83 % -
Payout Ratio (TTM) - 61.99 % - 39.56 % 75.84 % -
Profitability
AHPI ABT BSX-PA SYK MDT BSX
Gross Profit Margin TTM 55.51 % 69.01 % 63.54 % 62.27 % 69.01 %
Return on Assets TTM 7.75 % 6.77 % 6.78 % 5.22 % 6.77 %
Return on Equity TTM 13.18 % 12.87 % 15.04 % 9.83 % 12.87 %
Return on Capital Employed TTM 11.56 % 10.62 % 14.07 % 7.63 % 10.62 %
Net Income Per EBT TTM 77.06 % 85.38 % 71.91 % 83.61 % 85.38 %
EBT Per Ebit TTM 105.19 % 85.24 % 80.09 % 91.74 % 85.24 %
EBIT Per Revenue TTM 18.16 % 19.78 % 22.44 % 17.87 % 19.78 %
Cash Flow To Debt Ratio TTM 70.47 % 38.4 % 33.95 % 24.44 % 38.4 %
Receivables Turnover TTM 4.26 7.1 6.22 5.44 7.1
Payables Turnover TTM 4.78 6.21 - 5.08 6.21
Inventory Turnover TTM 2.94 2.13 1.72 2.13 2.13
Fixed Asset Turnover TTM 385.33 % 468.06 % 647.99 % 485.18 % 468.06 %
Asset Turnover TTM 52.66 % 47.01 % 52.5 % 38.05 % 47.01 %
Operating Cash Flow Per Share TTM 5.22 3.12 13.19 5.55 3.12
Free Cash Flow Per Share TTM 3.96 2.55 11.2 4.06 2.55
Cash Per Share TTM 442.64 % 85.99 % 1071.9 % 649.63 % 85.99 %
Operating Cash Flow Sales Ratio TTM 20.57 % 23.04 % 20.08 % 20.46 % 23.04 %
Free Cash Flow Operating Cash Flow Ratio TTM 75.85 % 81.6 % 84.91 % 73.19 % 81.6 %
Cash Flow Coverage Ratios TTM 70.47 % 38.4 % 33.95 % 24.44 % 38.4 %
Price To Free Cash Flows Ratio TTM 28.35 29.36 32.67 24.51 29.36
Price To Operating Cash Flows Ratio TTM 21.59 23.95 27.74 17.93 23.95
Price Cash Flow Ratio TTM 21.59 23.95 27.74 17.93 23.95
Income Statement (TTM)
AHPI ABT BSX-PA SYK MDT BSX
Revenue $0.03B $44.33B $20.07B $25.12B $33.54B $20.07B
Gross Profit $0B $24.61B $13.85B $15.43B $21.91B $13.85B
Gross Profit Ratio 9.34% 55.51% 69.01% 61.44% 65.32% 69.01%
EBITDA $-0B $11.33B $3.73B $5.69B $9.22B $3.73B
Net Income $-0.01B $6.52B $2.89B $3.25B $4.66B $2.89B
EPS Diluted -1.34 3.72 1.94 8.4 3.61 1.94
Balance Sheet (MRQ)
AHPI ABT BSX-PA SYK MDT BSX
Long Term Debt $0B $13.52B $9.37B $14.86B $25.64B $9.37B
Total Liabilities $0.01B $33.51B $17.39B $25.42B $43.42B $17.39B
Total Equity $0.01B $47.9B $22B $22.42B $48.26B $22B
Total Investments $0B $1.24B $0.56B $0.09B $6.75B $0.56B
Total Debt $0B $15.28B $11.15B $14.86B $28.52B $11.15B
Total Assets $0.02B $81.41B $39.4B $47.84B $91.68B $39.4B
Cash Flow Statement (TTM)
AHPI ABT BSX-PA SYK MDT BSX
Net Income $-0.01B $13.4B $1.85B $3.25B $4.69B $1.85B
Inventory $0B $-0.06B $-0.23B $0B $-0.29B $-0.23B
Dividends Paid $0B $-3.84B $0B $-1.28B $-3.59B $0B
Operating Cash Flow $-0B $8.56B $3.44B $5.04B $7.04B $3.44B
Capital Expenditure $-0B $-2.21B $-0.79B $-0.76B $-1.86B $-0.79B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 112.68
ADGM Adagio Medical Holdings, Inc. 0.985
AEMD Aethlon Medical, Inc. 1.96
AFIB Acutus Medical, Inc. 0.0002
AHCO AdaptHealth Corp. 10.2
ALGN Align Technology, Inc. 186.77
ALUR Allurion Technologies Inc. 1.12
AMIX Autonomix Medical, Inc. Common Stock 0.3833
ANIK Anika Therapeutics, Inc. 10.21
AORT Artivion, Inc. 36.6
APEN Apollo Endosurgery, Inc. 10
APYX Apyx Medical Corporation 3.72
ARAY Accuray Incorporated 0.5476
ASXC Asensus Surgical, Inc. 0.3479
ATEC Alphatec Holdings, Inc. 13.36
AVNS Avanos Medical, Inc. 14.9
AVR Anteris Technologies Global Corp. Common Stock 5.71
AXDX Accelerate Diagnostics, Inc. 0.034
AXGN AxoGen, Inc. 33.23
Unlock